Newleos
The Sr. Director, Regulatory Science at Newleos Therapeutics will shape and execute global regulatory strategies for clinical programs, serving as the primary liaison with FDA and EMA. Reporting to the CMO, this senior leader will oversee regulatory submissions, guide clinical development pathways, and collaborate cross‑functionally to ensure compliance and strategic alignment.
Newleos Therapeutics is a clinical-stage biotechnology company co-founded by Longwood Fund, focused on developing innovative treatments for mental health conditions. The company's pipeline, licensed from Roche, consists of oral small molecules targeting GABAA-γ1, V1a, TAAR1, and GABAA-α5 with first- or best-in-class potential. Its lead programs aim to treat general anxiety, social anxiety, substance use disorders, and cognitive impairment with improved outcomes over the current standard of care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Newleos.
Newleos didn’t post a salary, so this is our estimate from similar listings.
14% below the average for this role